<DOC>
	<DOCNO>NCT01393639</DOCNO>
	<brief_summary>The purpose study compare safety efficacy multiple dose PF-04171327 , experimental glucocorticoid drug , prednisone 5 mg 10 mg placebo treatment rheumatoid arthritis . All subject also receive background treatment methotrexate rheumatoid arthritis . Study medication give eight week follow 4 week period dose study medication gradually reduce . The efficacy study medication determine assess severity rheumatoid arthritis study safety determine adverse event reporting , laboratory test biomarker analysis .</brief_summary>
	<brief_title>Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Subjects must document rheumatoid arthritis duration least 3 month determine investigator use standardly accept criterion , must receive methotrexate least 3 month treat rheumatoid arthritis , must free sign symptoms infection . Subjects enter study recently receive treatment certain medication might interfere study medication ; subject enter abnormality certain blood test , history cancer , recent bone fracture significant condition .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>treatment rheumatoid arthritis</keyword>
	<keyword>treatment RA</keyword>
	<keyword>patient methotrexate rheumatoid arthritis</keyword>
	<keyword>prednisone rheumatoid arthritis</keyword>
</DOC>